Comparison of seizure duration, ictal EEG, and cognitive effects of ketamine and methohexital anesthesia with ECT
- PMID: 12556568
- DOI: 10.1176/jnp.15.1.27
Comparison of seizure duration, ictal EEG, and cognitive effects of ketamine and methohexital anesthesia with ECT
Abstract
The authors retrospectively compared the seizure duration, ictal EEG, and cognitive side effects of ketamine and methohexital anesthesia with ECT. This comparison was carried out with data from consecutive index ECT treatments that occurred immediately before and after a switch from methohexital to ketamine in 36 patients. Ketamine was well tolerated and prolonged seizure duration overall, but particularly in those who had a seizure duration shorter than 25 seconds with methohexital at the maximum available stimulus intensity. Ketamine also increased midictal EEG slow-wave amplitude. Thus, a switch to ketamine may be useful when it is difficult to elicit a robust seizure. Faster post-treatment reorientation with ketamine may suggest a lower level of associated cognitive side effects.
Similar articles
-
Propofol and methohexital as anesthetic agents for electroconvulsive therapy: a randomized, double-blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance.J ECT. 2007 Dec;23(4):239-43. doi: 10.1097/0b013e31814da971. J ECT. 2007. PMID: 18090696 Clinical Trial.
-
Can the bispectral index be used to predict seizure time and awakening after electroconvulsive therapy?Anesth Analg. 2003 Jun;96(6):1636-1639. doi: 10.1213/01.ANE.0000066018.13553.08. Anesth Analg. 2003. PMID: 12760987 Clinical Trial.
-
Post-electroconvulsive therapy recovery and reorientation time with methohexital and ketamine: a randomized, longitudinal, crossover design trial.J ECT. 2015 Mar;31(1):20-5. doi: 10.1097/YCT.0000000000000132. J ECT. 2015. PMID: 24755722 Free PMC article. Clinical Trial.
-
Some considerations of the tolerability of ketamine for ECT anesthesia: a case series and review of the literature.J ECT. 2014 Dec;30(4):283-6. doi: 10.1097/YCT.0000000000000100. J ECT. 2014. PMID: 24820945 Review.
-
[Clinical value of electroconvulsive therapy in treatment of depression].Wien Med Wochenschr. 1999;149(18):525-31. Wien Med Wochenschr. 1999. PMID: 10637958 Review. German.
Cited by
-
A comparative study of propofol, thiopentone sodium, and ketofol as induction agents for electro convulsive therapy.J Anaesthesiol Clin Pharmacol. 2021 Oct-Dec;37(4):554-560. doi: 10.4103/joacp.JOACP_423_19. Epub 2022 Jan 6. J Anaesthesiol Clin Pharmacol. 2021. PMID: 35340951 Free PMC article.
-
Electroconvulsive therapy (ECT) with ketamine induction for catatonia in an HIV positive patient.S Afr J Psychiatr. 2023 Jan 30;29:1944. doi: 10.4102/sajpsychiatry.v29i0.1944. eCollection 2023. S Afr J Psychiatr. 2023. PMID: 36756540 Free PMC article.
-
Study protocol for the randomised controlled trial: Ketamine augmentation of ECT to improve outcomes in depression (Ketamine-ECT study).BMC Psychiatry. 2015 Oct 21;15:257. doi: 10.1186/s12888-015-0641-4. BMC Psychiatry. 2015. PMID: 26489663 Free PMC article. Clinical Trial.
-
Ketamine for depression: where do we go from here?Biol Psychiatry. 2012 Oct 1;72(7):537-47. doi: 10.1016/j.biopsych.2012.05.003. Epub 2012 Jun 16. Biol Psychiatry. 2012. PMID: 22705040 Free PMC article.
-
Administration of Sub-anesthetic Dose of Ketamine and Electroconvulsive Treatment on Alternate Week Days in Patients with Treatment Resistant Depression: A Double Blind Placebo Controlled Trial.Psychopharmacol Bull. 2019 Feb 15;49(1):8-16. Psychopharmacol Bull. 2019. PMID: 30858635 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical